Catastrophic Antiphospholipid Syndrome

Rheumatic Disease Clinics of North America

Volumn 32, Issue 3, 2006, Pages 575-590

  Cervera, Ricard ^a   Asherson, Ronald A ^b   Font, Josep ^a  

^a HOSPITAL CLÍNIC   (Spain)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ANCROD; ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; CIPROFLOXACIN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DEFIBROTIDE; FIBRINOLYTIC AGENT; HEPARIN; IMMUNOGLOBULIN; INOTROPIC AGENT; PHOSPHOLIPID ANTIBODY; PROSTACYCLIN; QUINOLINE DERIVATIVE; RITUXIMAB; STEROID; STREPTOKINASE; TISSUE PLASMINOGEN ACTIVATOR; TOLL LIKE RECEPTOR; UROKINASE; WARFARIN;

ANTIPHOSPHOLIPID SYNDROME; BLEEDING; BLOOD VESSEL OCCLUSION; CANCER; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; HISTOPATHOLOGY; HUMAN; INFECTION; INJURY; INTENSIVE CARE UNIT; KIDNEY FAILURE; LABORATORY TEST; MULTIPLE ORGAN FAILURE; NONHUMAN; PATHOGENESIS; PHYSICIAN; PLASMAPHERESIS; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SURGICAL TECHNIQUE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTOPENIA; THROMBOEMBOLISM; THROMBOSIS;

ANTICOAGULANTS; ANTIPHOSPHOLIPID SYNDROME; CATASTROPHIC ILLNESS; COMBINED MODALITY THERAPY; EARLY DIAGNOSIS; GLUCOCORTICOIDS; HEPARIN; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; MULTIPLE ORGAN FAILURE; PLASMA EXCHANGE; THROMBOSIS;

EID: 33746375339     PISSN: 0889857X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rdc.2006.05.002     Document Type: Review

References (31)

1. Asherson R.A. The catastrophic antiphospholipid antibody syndrome. J Rheumatol 19 (1992) 508-512
2. Piette J.C., Cervera R., Levy R., et al. The catastrophic antiphospholipid syndrome-Asherson's syndrome. Ann Med Intern 154 (2003) 95-96
3. Greisman S.G., Thayaparan R.-S., Godwin T.A., et al. Occlusive vasculopathy in systemic lupus erythematosus-association with anticardiolipin antibody. Arch Intern Med 151 (1991) 389-392
4. Harris E.N., and Bos K. An acute disseminated coagulopathy-vasculopathy associated with the antiphopholipid syndrome. Arch Intern Med 151 (1991) 231-232
5. Asherson R.A., Cervera R., Piette J.C., et al. Catastrophic antiphospholipid syndrome. Clinical and laboratory features of 50 patients. Medicine (Baltimore) 77 (1998) 195-207
6. Asherson R.A., Cervera R., Piette J.C., et al. Catastrophic antiphospholipid syndrome: clues to the pathogenesis from a series of 80 patients. Medicine (Baltimore) 80 (2001) 355-376
7. Cervera R., Piette J.C., Font J., et al. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum 46 (2002) 1019-1027
8. Cervera R, Font J, Tincani A, et al. V Meeting of the European Forum on Antiphospholipid Antibodies. Autoimmun Rev, in press.
9. Asherson R.A., Cervera R., de Groot P., et al. Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines. Lupus 12 (2003) 530-534
10. Cervera R., Font J., Gómez-Puerta J.A., et al. Validation of the preliminary criteria for the classification of catastrophic antiphospholipid syndrome. Ann Rheum Dis 64 (2005) 1205-1209
11. Asherson R.A., and Shoenfeld Y. The role of infection in the pathogenesis of catastrophic antiphospholipid syndrome-molecular mimicry?. J Rheumatol 27 (2000) 12-14
12. Gharavi E., Cucurull E., Tang H., et al. Induction of antiphospholipid antibodies by immunization with viral peptides. Lupus 8 (1999) 449-455
13. Gharavi A.E., Pierangeli S.S., and Harris N. New developments in viral peptides and antiphospholipid antibody induction. J Autoimmun 15 (2000) 227-230
14. Shoenfeld Y., Blank M., Cervera R., et al. Infectious origin of the antiphospholipid syndrome. Ann Rheum Dis 65 (2006) 2-6
15. Gómez-Puerta J.A., Cervera R., Espinosa G., et al. Antiphospholipid antibodies associated with malignancies: clinical and pathological characteristics of 120 patients. Semin Arthritis Rheum 35 (2006) 322-332
16. Kitchens C.S. Thrombotic storm: when thrombosis begets thrombosis. Am J Med 104 (1998) 381-385
17. Amital H., Levy Y., Davidson C., et al. Catastrophic antiphospholipid syndrome: remission following leg amputation. Semin Arthritis Rheum 31 (2001) 127-132
18. Pierangeli S.S., Girardi G., Vega-Ostertag M., et al. Requirement of activation of complement C3 and C5 for antiphospholipid antibody mediated thrombosis. Arthritis Rheum 52 (2005) 2120-2124
19. Salmon J.E., Girardi G., and Holers V.M. Activation of complement mediates antiphospholipid antibody-induced pregnancy loss. Lupus 12 (2003) 535-538
20. Hart M.L., Keonzo K.A., Shaffer L.A., et al. Gastrointestinal ischemia-reperfusion is lectin complement pathway dependent without involving C1q. J Immunol 174 (2005) 6373-6380
21. Fleming S.D., Egan R.E., Chai C., et al. Anti-phospholipid antibodies restore mesenteric ischemia reperfusion-induced injury in complement receptor 2/complement receptor 1-deficient mice. J Immunol 173 (2005) 7055-7061
22. Bucciarelli S., Espinosa G., Asherson R.A., et al. The acute respiratory distress syndrome in catastrophic antiphospholipid syndrome: analysis of a series of 47 patients. Ann Rheum Dis 65 (2006) 81-86
23. Undas A., Swadzba J., Undas R., et al. Three episodes of acute multiorgan failure in a woman with secondary antiphospholipid syndrome. Pol Arch Med Wewn 100 (1998) 556-560
24. Cerveny K.C., and Sawitzke A.D. Relapsing catastrophic antiphospholipid antibody syndrome: a mimic for thrombotic thrombocytopenic purpura?. Lupus 8 (1999) 477-481
25. Gordon A., McLean C.A., Ryan P., et al. Steroid-responsive catastrophic antiphospholipid syndrome. J Gastroenterol Hepatol 19 (2004) 479-480
26. Belmont H.M., Abramson S.B., and Lie J.T. Pathology and pathogenesis of vascular injury in systemic lupus erythematosus. Arthritis Rheum 39 (1996) 9-22
27. Asherson R.A., Espinosa G., Cervera R., et al. Disseminated intravascular coagulation in catastrophic antiphospholipid syndrome: clinical and haematological characteristics of 23 patients. Ann Rheum Dis 64 (2005) 943-946
28. Espinosa G., Bucciarelli S., Cervera R., et al. Thrombotic microangiopathic haemolytic anaemia and antiphospholipid antibodies. Ann Rheum Dis 63 (2004) 730-736
29. Ehresmann S., Arkfeld D., Shinada S., et al. A novel therapeutic approach for catastrophic antiphospholipid syndrome (CAPS) when conventional therapy with anticoagulants and steroids were unsuccessful. Ann Rheum Dis 64 Supp1 (2004) FR10278 (abstr.) 70
30. Bucciarelli S, Espinosa G, Cervera R, et al. Mortality in the catastrophic antiphospholipid syndrome: Causes of death and prognostic factors in a series of 250 patients. Arthritis Rheum, in press.
31. Erkan D., Asherson R.A., Espinosa G., et al. The long-term outcome of catastrophic antiphospholipid syndrome survivors. Ann Rheum Dis 62 (2003) 530-533